SCHEMBL5053642

SCHEMBL5053642

CCCCCCOc1ccc(-c2cn(CC)nn2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.50
KDM4E B2RXH2 3/20 0.50
ALDH1A1 P00352 3/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
HPGD P15428 2/20 0.50
HTT P42858 1/20 0.50
NPC1 O15118 4/20 0.48
RAB9A P51151 4/20 0.48
ATM Q13315 1/20 0.48
CYP2D6 P10635 6/20 0.48
CYP2C9 P11712 4/20 0.48
CYP2C19 P33261 4/20 0.48
CYP1A2 P05177 3/20 0.48
NR5A1 Q13285 1/20 0.46
RARB P10826 3/20 0.46
CYP3A4 P08684 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5049451 0.96 CYP19A1 (0.54) CYP19A1KDM4EALDH1A1L3MBTL1HPGD
SCHEMBL16263167 0.85 CYP2D6 (0.47) CYP19A1KDM4EALDH1A1L3MBTL1HPGD
SCHEMBL28525427 0.85 CYP19A1 (0.60) CYP19A1L3MBTL1NPC1RAB9AATM
SCHEMBL18925015 0.81 MEN1 (0.64) NPC1RAB9AMEN1KMT2A
SCHEMBL4216458 0.79 HDAC3 (0.66) L3MBTL1NPC1RAB9AMEN1KMT2A
SCHEMBL5051923 0.77 HDAC3 (0.64) L3MBTL1NPC1RAB9AMEN1KMT2A
SCHEMBL5049564 0.77 MEN1 (0.49) NPC1RAB9ACYP1A2MEN1KMT2A
SCHEMBL29966023 0.76 MEN1 (0.49) CYP19A1KDM4EALDH1A1L3MBTL1NPC1
SCHEMBL16264735 0.75 MEN1 (0.50) CYP19A1L3MBTL1NPC1RAB9AMEN1
SCHEMBL7775244 0.75 RARB (0.71) CYP19A1KDM4EALDH1A1L3MBTL1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1921072-A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP claimed
EP-1921072-A1 1,2,3-Triazole derivatives as cannabinoid-receptor modulators Laboratorios del Dr. Esteve S.A. (ES) 2008-05-14 EP disclosed